Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_38774 | 13 | 0.28 | Mlig455_056173, Mlig455_058730 | Neo: - Age: - |
GALR2 | Mlig455_056173 {REF} {Length: 2381} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=152.4]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=35.1]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=20.1]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=50.4, Expect=4e-06]; ENSG00000180269, GPR139, G protein-coupled receptor 139, [Score=48.1, Expect=1e-05]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=53.5, Expect=2e-07]} {Dmel: FBgn0033579, CG13229, [Score=179, Expect=1e-51]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=218, Expect=1e-66]} {Smed: dd_Smed_v6_15468_0_1, dd_Smed_v6_15468_0_1, [Score=248, Expect=2e-78]} {RNA1310_25407.1} {RNA815_38269} Mlig455_058730 {REF} {Length: 2507} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=123.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=31.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Dmel: FBgn0033579, CG13229, [Score=139, Expect=6e-37]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=175, Expect=5e-50]} {Smed: dd_Smed_v6_15468_0_2, dd_Smed_v6_15468_0_2, [Score=209, Expect=2e-63]} {RNA1310_25407.1} {RNA815_42074} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 4.472 | 0.769 | 0.99991 | 1.00000 | |
RegionR2 | 1.615 | 0.769 | 0.91217 | 1.00000 | |
RegionR3 | 2.222 | 0.769 | 0.40354 | 0.93126 | |
RegionR4 | 1.202 | 0.769 | 0.99968 | 1.00000 | |
RegionR5 | -2.7 | 0.769 | 0.99981 | 1.00000 | |
RegionR6 | -3.083 | 0.769 | 0.99971 | 1.00000 | |
RegionR7 | -1.867 | 0.769 | 0.99955 | 1.00000 | |
RegionR8 | -1.861 | 0.769 | 0.99958 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -4.678 | 0.769 | 0.99983 | 1.00000 | |
RegenerationR2 | -1.969 | 0.769 | 0.10502 | 0.50996 | |
RegenerationR3 | -2.628 | 0.769 | 0.01739 | 0.24042 | |
RegenerationR4 | -2.142 | 0.769 | 0.99984 | 1.00000 | |
RegenerationR5 | -1.046 | 0.769 | 0.99988 | 1.00000 | |
RegenerationR6 | -0.899 | 0.769 | 0.99992 | 1.00000 | |
RegenerationBL | -0.92 | 0.769 | 0.99995 | 1.00000 | |
RegenerationTP | -1.781 | 0.769 | 0.99983 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_38774 | 13 | 0.28 | Mlig455_056173, Mlig455_058730 | Neo: - Age: - |
GALR2 | 4 | 1.000 | 1.000 | 1.000 | - | 1.000 | - | Mlig455_056173 {REF} {Length: 2381} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=152.4]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=35.1]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=20.1]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=50.4, Expect=4e-06]; ENSG00000180269, GPR139, G protein-coupled receptor 139, [Score=48.1, Expect=1e-05]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=53.5, Expect=2e-07]} {Dmel: FBgn0033579, CG13229, [Score=179, Expect=1e-51]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=218, Expect=1e-66]} {Smed: dd_Smed_v6_15468_0_1, dd_Smed_v6_15468_0_1, [Score=248, Expect=2e-78]} {RNA1310_25407.1} {RNA815_38269} Mlig455_058730 {REF} {Length: 2507} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=123.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=31.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Dmel: FBgn0033579, CG13229, [Score=139, Expect=6e-37]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=175, Expect=5e-50]} {Smed: dd_Smed_v6_15468_0_2, dd_Smed_v6_15468_0_2, [Score=209, Expect=2e-63]} {RNA1310_25407.1} {RNA815_42074} |
2. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
2.756 | 0.966 | - | 0.977 | - | 0.813 | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
3. | MligTC455_19487 | 14 | 0.28 | Mlig455_044811, Mlig455_055571 | Neo: - Age: - |
KCTD15 | 2.695 | 0.961 | - | 1.000 | - | 0.734 | - | Mlig455_044811 {REF} {Length: 1188} {Pfam: BTB/POZ domain [PF02214.24, score=67.6]} {Human: ENSG00000153885, KCTD15, potassium channel tetramerization domain containing 15, [RH, Score=253, Expect=3e-83]; ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [RH, Score=243, Expect=1e-73]} {Mouse: ENSMUSG00000030499, Kctd15, potassium channel tetramerisation domain containing 15, [RH, Score=254, Expect=6e-84]; ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [RH, Score=243, Expect=1e-73]} {Dmel: FBgn0034636, twz, tiwaz, [RH, Score=252, Expect=2e-82]} {Celegans: WBGene00016549, C40A11.6, [Score=57.4, Expect=1e-09]} {Smed: dd_Smed_v6_28887_0_1, dd_Smed_v6_28887_0_1, [RH, Score=184, Expect=3e-56]} {RNA1509_6075} {RNA1310_4175} {RNA815_1202.1} Mlig455_055571 {REF} {Length: 1181} {Pfam: BTB/POZ domain [PF02214.24, score=67.2]} {Human: ENSG00000153885, KCTD15, potassium channel tetramerization domain containing 15, [RH, Score=253, Expect=3e-83]; ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [RH, Score=243, Expect=2e-73]} {Mouse: ENSMUSG00000030499, Kctd15, potassium channel tetramerisation domain containing 15, [RH, Score=254, Expect=6e-84]; ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [RH, Score=243, Expect=1e-73]} {Dmel: FBgn0034636, twz, tiwaz, [RH, Score=250, Expect=1e-81]} {Celegans: WBGene00016549, C40A11.6, [Score=57.4, Expect=1e-09]} {Smed: dd_Smed_v6_28887_0_1, dd_Smed_v6_28887_0_1, [RH, Score=185, Expect=9e-57]} {RNA1509_6075} {RNA1310_4175} {RNA815_1202.1} |
4. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
2.68 | 0.961 | - | 0.983 | - | 0.736 | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
5. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
2.612 | 0.964 | - | 0.908 | - | 0.740 | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
6. | MligTC455_48692 | 15 | 0.32 | Mlig455_021398 | Neo: - Age: - Region-enriched R2: 8.096/0.02429 |
2.587 | 0.952 | - | 0.847 | - | 0.788 | - | Mlig455_021398 {REF} {Length: 1571} {Pfam: Ankyrin repeat [PF00023.32, score=20.9]; Ankyrin repeats (many copies) [PF13637.8, score=20.4]; Ankyrin repeats (many copies) [PF13857.8, score=19.6]; Ankyrin repeats (3 copies) [PF12796.9, score=19.4]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=54.7, Expect=3e-08]} {RNA1310_69005} | |
7. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
2.534 | 0.850 | - | 0.963 | - | 0.721 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
8. | MligTC455_48604 | 173 | 3.6 | Mlig455_031074 | Neo: - |
2.517 | 0.969 | - | 0.798 | - | 0.750 | - | Mlig455_031074 {REF} {Length: 652} {RNA1310_66509} | |
9. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
2.494 | 0.777 | - | 0.964 | - | 0.753 | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
10. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
2.48 | 0.965 | - | 0.804 | - | 0.711 | - | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
11. | MligTC455_35813 | 35 | 0.73 | Mlig455_013562, Mlig455_013615 | Neo: - Age: - Region-enriched R2: 7.733/0.00085 |
NPR2 | 2.447 | 0.966 | - | 0.750 | - | 0.731 | - | Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869} Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407} |
12. | MligTC455_27331 | 2162 | 45.05 | Mlig455_034840 | Neo: - Age: logFC(26M/2M)=-0.500 Region-specific R2: 5.384 Region-enriched R2: 4.962/0.00000 Regeneration-downregulated R2: -3.612 Regeneration-depleted R2: -3.612 |
2.441 | 0.717 | - | 0.991 | - | 0.733 | - | Mlig455_034840 {REF} {Length: 2399} {TRANSSPLICED} {RNA1509_22512, RNA1509_3017, RNA1509_47207} {RNA1310_16498, RNA1509_3017, RNA1509_47207} {RNA1509_3017, RNA1509_47207, RNA815_17345} | |
13. | MligTC455_36193 | 13 | 0.27 | Mlig455_025794 | Neo: - Age: - |
B3GNT4 | 2.43 | 0.990 | - | 0.724 | - | 0.716 | - | Mlig455_025794 {REF} {Length: 3112} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=1e-20]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.2, Expect=3e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=89.7, Expect=1e-18]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
14. | MligTC455_46712 | 29 | 0.6 | Mlig455_034008 | Neo: - Age: - |
1.958 | 0.960 | - | 0.998 | - | - | - | Mlig455_034008 {REF} {Length: 413} {RNA1509_3272} {RNA1310_44997} {RNA815_30824} | |
15. | MligTC455_17871 | 73 | 1.51 | Mlig455_059152, Mlig455_059165, Mlig455_065536 | Neo: - Age: - |
1.957 | 0.966 | - | 0.991 | - | - | - | Mlig455_059152 {REF} {Length: 321} {NoTransDecoderORF} Mlig455_059165 {REF} {Length: 3349} {Pfam: PIF1-like helicase [PF05970.16, score=103.7]; Helitron helicase-like domain at N-terminus [PF14214.8, score=34.7]} {Celegans: WBGene00018020, F33H12.6, [Score=246, Expect=7e-67]} {Smed: dd_Smed_v6_22430_0_5, dd_Smed_v6_22430_0_5, [Score=47.0, Expect=6e-07]} {RNA1310_3236.1} {RNA815_8758} Mlig455_065536 {REF} {Length: 321} {NoTransDecoderORF} |
|
16. | MligTC455_01965 | 13 | 0.27 | Mlig455_003624 | Neo: - Age: - |
1.944 | - | - | 1.000 | - | 0.944 | - | Mlig455_003624 {REF} {Length: 925} {NoTransDecoderORF} {RNA1509_51359} {RNA1310_110172} | |
17. | MligTC455_51972 | 11 | 0.23 | Mlig455_033085 | Neo: - Age: - |
1.931 | 0.993 | - | 0.938 | - | - | - | Mlig455_033085 {REF} {Length: 3061} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=31.3]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=48.5, Expect=5e-06]} {RNA1310_30135} {RNA815_28427} | |
18. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.929 | 0.929 | - | 1.000 | - | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
19. | MligTC455_19775 | 36 | 0.74 | Mlig455_060359 | Neo: - Age: - |
FCN1 | 1.927 | 0.966 | - | - | - | 0.961 | - | Mlig455_060359 {REF} {Length: 1109} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=99.0, Expect=2e-23]; ENSG00000142748, FCN3, ficolin 3, [Score=99.0, Expect=1e-23]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=2e-23]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=3e-24]} {Dmel: FBgn0034160, CG5550, [Score=97.8, Expect=7e-24]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_67383} {RNA815_45536} |
20. | MligTC455_25701 | 31 | 0.65 | Mlig455_017477 | Neo: - Age: - |
1.922 | 0.966 | - | 0.956 | - | - | - | Mlig455_017477 {REF} {Length: 664} {RNA1310_52753} {RNA815_26527} | |
21. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 1.918 | 0.918 | - | 1.000 | - | - | - | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
22. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
1.913 | 0.966 | - | - | - | 0.947 | - | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
23. | MligTC455_41738 | 22 | 0.45 | Mlig455_049770 | Neo: - Age: - |
PCIF1 | 1.91 | - | - | 1.000 | - | 0.910 | - | Mlig455_049770 {REF} {Length: 2631} {Pfam: Phosphorylated CTD interacting factor 1 WW domain [PF12237.10, score=100.0]} {Human: ENSG00000100982, PCIF1, PDX1 C-terminal inhibiting factor 1, [Score=63.2, Expect=3e-10]} {Mouse: ENSMUSG00000039849, Pcif1, PDX1 C-terminal inhibiting factor 1, [Score=62.4, Expect=4e-10]} {Smed: dd_Smed_v6_4647_0_1, dd_Smed_v6_4647_0_1, [Score=162, Expect=8e-46]} {RNA1310_17554.1} {RNA815_8653} |
24. | MligTC455_15099 | 26 | 0.54 | Mlig455_057991, Mlig455_058185 | Neo: - Age: - Region-enriched R4: 8.074/0.00255 |
PCDH9 | 1.906 | 0.906 | - | 1.000 | - | - | - | Mlig455_057991 {REF} {Length: 5180} {Pfam: Cadherin domain [PF00028.19, score=245.9]; Cadherin-like [PF16184.7, score=32.1]; Cadherin-like [PF08266.14, score=31.0]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=277, Expect=2e-77]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=277, Expect=4e-77]} {Dmel: FBgn0001075, ft, fat, [Score=211, Expect=5e-55]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=171, Expect=7e-43]} {Smed: dd_Smed_v6_16566_0_2, dd_Smed_v6_16566_0_2, [Score=317, Expect=1e-92]} {RNA1509_38512} {RNA1310_81930} Mlig455_058185 {REF} {Length: 2168} {RNA1310_95463.1} |
25. | MligTC455_36944 | 22 | 0.45 | Mlig455_065298, Mlig455_065320 | Neo: - Age: Up-Down-Up |
NR2F1 | 1.899 | 0.976 | - | - | - | 0.923 | - | Mlig455_065298 {REF} {Length: 2485} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=100.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=95.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [RH, Score=241, Expect=4e-73]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [RH, Score=240, Expect=2e-72]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [RH, Score=240, Expect=1e-72]} {Dmel: FBgn0003651, svp, seven up, [RH, Score=240, Expect=3e-71]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [RH, Score=150, Expect=4e-40]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [RH, Score=211, Expect=4e-61]} Mlig455_065320 {REF} {Length: 3080} {Pfam: Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=76.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=215, Expect=6e-67]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [Score=214, Expect=5e-66]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=215, Expect=2e-68]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=214, Expect=4e-66]} {Dmel: FBgn0003651, svp, seven up, [Score=211, Expect=2e-66]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [Score=69.3, Expect=4e-13]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [Score=183, Expect=9e-54]} |
26. | MligTC455_24568 | 25 | 0.51 | Mlig455_038127 | Neo: - Age: Down-Up-Down |
CACNA2D2 | 1.892 | 0.892 | - | 1.000 | - | - | - | Mlig455_038127 {REF} {Length: 4202} {Pfam: von Willebrand factor type A domain [PF13519.8, score=41.5]; von Willebrand factor type A domain [PF00092.30, score=36.2]; von Willebrand factor type A domain [PF13768.8, score=30.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=82.8, Expect=2e-16]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=79.3, Expect=3e-15]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=79.0, Expect=4e-15]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=82.4, Expect=2e-16]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=79.3, Expect=3e-15]} {Celegans: WBGene00007041, tag-180, [Score=62.0, Expect=4e-10]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=430, Expect=2e-140]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
27. | MligTC455_36643 | 194 | 4.04 | Mlig455_041343 | Neo: - Age: Up-Down-Up |
1.881 | 0.907 | - | 0.974 | - | - | - | Mlig455_041343 {REF} {Length: 847} {RNA1509_40031} {RNA1310_41959.1} {RNA815_19701} | |
28. | MligTC455_10216 | 85 | 1.77 | Mlig455_028808 | Neo: - Age: - |
1.878 | 0.886 | - | 0.992 | - | - | - | Mlig455_028808 {REF} {Length: 1548} {RNA1509_32459} {RNA1310_2760.1} {RNA815_33964} | |
29. | MligTC455_21967 | 46 | 0.96 | Mlig455_059500 | Neo: - Age: logFC(26M/2M)=-0.481 |
1.877 | 0.877 | - | 1.000 | - | - | - | Mlig455_059500 {REF} {Length: 3977} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=186.4]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=53.5, Expect=6e-07]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=382, Expect=8e-125]} {RNA1509_57431} {RNA1310_11500} {RNA815_5893} | |
30. | MligTC455_29263 | 141 | 2.94 | Mlig455_011098, Mlig455_058075 | Neo: - |
1.868 | - | - | 0.976 | - | 0.892 | - | Mlig455_011098 {REF} {Length: 8375} {RNA1509_9188} {RNA1310_63.1} {RNA815_23.1} Mlig455_058075 {REF} {Length: 10281} {RNA1509_39758, RNA1509_41143, RNA1509_9188} {RNA1310_234.1, RNA1509_39758, RNA1509_41143, RNA1509_9188} {RNA1509_39758, RNA1509_41143, RNA1509_9188, RNA815_23.1} |
|
31. | MligTC455_08808 | 98 | 2.04 | Mlig455_029074 | Neo: - Age: - Region-enriched R2: 8.479/0.00000 |
1.866 | 0.961 | - | 0.905 | - | - | - | Mlig455_029074 {REF} {Length: 722} {RNA1310_65090} {RNA815_34420} | |
32. | MligTC455_14022 | 12 | 0.25 | Mlig455_007794 | Neo: - Age: - |
1.862 | - | - | 1.000 | - | 0.862 | - | Mlig455_007794 {REF} {Length: 2783} {RNA1310_91563} | |
33. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
1.851 | 0.965 | - | 0.886 | - | - | - | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
34. | MligTC455_49664 | 37 | 0.78 | Mlig455_013619 | Neo: - Age: - |
CDH23 | 1.837 | 0.837 | - | 1.000 | - | - | - | Mlig455_013619 {REF} {Length: 7298} {Pfam: Cadherin domain [PF00028.19, score=360.9]; Cadherin-like [PF08266.14, score=37.5]} {Human: ENSG00000107736, CDH23, cadherin related 23, [Score=372, Expect=1e-103]} {Mouse: ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=374, Expect=2e-104]} {Dmel: FBgn0038247, Cad88C, Cadherin 88C, [Score=362, Expect=3e-101]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=224, Expect=2e-58]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [Score=414, Expect=2e-118]} {RNA1509_16482} {RNA1310_682} {RNA815_249} |
35. | MligTC455_15565 | 122 | 2.54 | Mlig455_054610, Mlig455_060123 | Neo: - Age: - |
1.825 | - | 0.825 | 1.000 | - | - | - | Mlig455_054610 {REF} {Length: 609} {NoTransDecoderORF} {RNA1310_55174} {RNA815_12298} Mlig455_060123 {REF} {Length: 624} {NoTransDecoderORF} {RNA1310_55174} {RNA815_12298} |
|
36. | MligTC455_49304 | 46 | 0.95 | Mlig455_044321 | Neo: - Age: - |
1.825 | 0.871 | - | 0.954 | - | - | - | Mlig455_044321 {REF} {Length: 701} {RNA1509_20965} {RNA1310_92283} | |
37. | MligTC455_27186 | 28 | 0.57 | Mlig455_010236 | Neo: - Age: logFC(26M/2M)=-1.855 |
1.823 | - | 0.845 | 0.978 | - | - | - | Mlig455_010236 {REF} {Length: 486} {RNA1509_7146} {RNA1310_76234.2} {RNA815_34947.2} | |
38. | MligTC455_24470 | 37 | 0.76 | Mlig455_020119 | Neo: - Age: - |
1.813 | 0.966 | - | 0.847 | - | - | - | Mlig455_020119 {REF} {Length: 1150} {Pfam: Pancreatic hormone peptide [PF00159.20, score=22.9]} {RNA1310_54016} {RNA815_51613} | |
39. | MligTC455_25855 | 42 | 0.88 | Mlig455_018398, Mlig455_069528 | Neo: - Age: - Region-enriched R2: 9.088/0.00001 |
RGS6 | 1.813 | 0.966 | - | 0.847 | - | - | - | Mlig455_018398 {REF} {Length: 4715} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=112.3]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.7]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=312, Expect=2e-98]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=308, Expect=6e-97]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=307, Expect=1e-96]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=303, Expect=3e-95]} {Dmel: FBgn0259927, CG42450, [Score=313, Expect=1e-92]} {Celegans: WBGene00001145, eat-16, [RH, Score=238, Expect=7e-71]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=390, Expect=8e-129]} {RNA1509_28579} {RNA1310_55167} {RNA815_31676} Mlig455_069528 {REF} {Length: 5061} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=112.2]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.7]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=312, Expect=3e-98]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=308, Expect=1e-96]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=307, Expect=2e-96]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=303, Expect=7e-95]} {Dmel: FBgn0259927, CG42450, [Score=314, Expect=8e-93]} {Celegans: WBGene00001145, eat-16, [RH, Score=239, Expect=6e-71]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=391, Expect=9e-129]} {RNA1509_28579} {RNA1310_24067} {RNA815_31676} |
40. | MligTC455_25703 | 225 | 4.7 | Mlig455_017402, Mlig455_030916 | Neo: - Age: - |
1.805 | 0.966 | - | 0.839 | - | - | - | Mlig455_017402 {REF} {Length: 899} {RNA1310_52753} {RNA815_26527} Mlig455_030916 {REF} {Length: 700} {RNA1310_52753} {RNA815_26527} |
|
41. | MligTC455_04110 | 13 | 0.27 | Mlig455_065812 | Neo: - Age: - |
1.8 | - | - | 1.000 | - | 0.800 | - | Mlig455_065812 {REF} {Length: 2664} {RNA1310_86305} | |
42. | MligTC455_33495 | 28 | 0.58 | Mlig455_047292, Mlig455_047342, Mlig455_069323 | Neo: - Age: - |
LHFPL2 | 1.798 | 0.798 | - | 1.000 | - | - | - | Mlig455_047292 {REF} {Length: 1105} {RNA1310_118047} Mlig455_047342 {REF} {Length: 1735} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=104.8]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=30.7]} {Human: ENSG00000145685, LHFPL2, LHFPL tetraspan subfamily member 2, [Score=47.8, Expect=1e-05]} {Mouse: ENSMUSG00000045312, Lhfpl2, lipoma HMGIC fusion partner-like 2, [Score=47.0, Expect=1e-05]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [Score=175, Expect=1e-51]} {RNA1509_30020} {RNA1310_118047} {RNA815_5159.1} Mlig455_069323 {REF} {Length: 886} {RNA1310_118047} |
43. | MligTC455_12113 | 72 | 1.5 | Mlig455_001687, Mlig455_071131 | Neo: - Age: - |
1.793 | 0.802 | - | 0.991 | - | - | - | Mlig455_001687 {REF} {Length: 809} {RNA1310_67367} {RNA815_37220} Mlig455_071131 {REF} {Length: 452} {RNA1509_45496} {RNA1310_67367} {RNA815_37220} |
|
44. | MligTC455_28807 | 8 | 0.17 | Mlig455_024214 | Neo: - Age: - |
ANK3 | 1.792 | 0.792 | - | 1.000 | - | - | - | Mlig455_024214 {REF} {Length: 4338} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=66.9]; Ankyrin repeats (many copies) [PF13637.8, score=64.7]; Ankyrin repeats (many copies) [PF13857.8, score=61.7]; Ankyrin repeat [PF13606.8, score=45.7]; Ankyrin repeat [PF00023.32, score=33.4]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=80.5, Expect=2e-14]; ENSG00000029534, ANK1, ankyrin 1, [Score=79.3, Expect=3e-14]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=82.0, Expect=3e-15]; ENSMUSG00000021559, Dapk1, death associated protein kinase 1, [Score=81.6, Expect=4e-15]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=78.2, Expect=6e-14]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=75.1, Expect=2e-13]} {Smed: dd_Smed_v6_7952_0_1, dd_Smed_v6_7952_0_1, [Score=75.5, Expect=1e-13]} {RNA1310_91471} |
45. | MligTC455_34232 | 35 | 0.73 | Mlig455_051899 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.310 Region-enriched R3: 6.749/0.02565 |
ACR | 1.785 | - | 0.801 | 0.984 | - | - | - | Mlig455_051899 {REF} {Length: 1242} {Pfam: Trypsin [PF00089.28, score=169.8]} {Human: ENSG00000100312, ACR, acrosin, [Score=154, Expect=5e-43]; ENSG00000283539, ACR, acrosin, [Score=154, Expect=5e-43]; ENSG00000198670, LPA, lipoprotein(a), [Score=152, Expect=3e-40]; ENSG00000122194, PLG, plasminogen, [Score=152, Expect=1e-40]; ENSG00000178297, TMPRSS9, transmembrane serine protease 9, [Score=148, Expect=5e-39]; ENSG00000103355, PRSS33, serine protease 33, [Score=148, Expect=5e-42]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=150, Expect=5e-40]; ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=148, Expect=2e-39]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=144, Expect=6e-38]} {Dmel: FBgn0036287, CG10663, [Score=129, Expect=8e-33]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=122, Expect=2e-32]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [Score=172, Expect=4e-51]} {RNA1509_37786} {RNA1310_26421} {RNA815_13601} |
46. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.783 | 0.792 | - | 0.991 | - | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
47. | MligTC455_12525 | 11 | 0.23 | Mlig455_067862 | Neo: - Age: - |
1.781 | - | - | 0.968 | - | 0.813 | - | Mlig455_067862 {REF} {Length: 1730} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=44.0]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=18.1]} {Smed: dd_Smed_v6_13661_0_2, dd_Smed_v6_13661_0_2, [Score=80.9, Expect=3e-17]} {RNA1509_20770} {RNA1310_58410} {RNA815_35907} | |
48. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 1.779 | 0.779 | - | 1.000 | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
49. | MligTC455_14631 | 14 | 0.29 | Mlig455_050544, Mlig455_050576, Mlig455_064509 | Neo: - Age: - |
1.777 | 0.777 | - | 1.000 | - | - | - | Mlig455_050544 {REF} {Length: 1805} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=22.9]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {Smed: dd_Smed_v6_42201_0_1, dd_Smed_v6_42201_0_1, [RH, Score=143, Expect=3e-39]} {RNA1310_90332} Mlig455_050576 {REF} {Length: 2140} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.6]} {Smed: dd_Smed_v6_42201_0_1, dd_Smed_v6_42201_0_1, [Score=141, Expect=6e-38]} {RNA1310_90332} Mlig455_064509 {REF} {Length: 2125} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=23.1]} {Smed: dd_Smed_v6_42201_0_1, dd_Smed_v6_42201_0_1, [Score=143, Expect=2e-38]} {RNA1310_90332} |
|
50. | MligTC455_40341 | 106 | 2.2 | Mlig455_060207, Mlig455_070456 | Neo: - Age: Down-Down-Up Region-enriched R2: 6.703/0.00648 |
NPY2R | 1.775 | - | - | 0.980 | - | 0.795 | - | Mlig455_060207 {REF} {Length: 3062} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=177.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=178, Expect=9e-51]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=176, Expect=3e-50]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=176, Expect=1e-49]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [Score=245, Expect=4e-74]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=215, Expect=5e-65]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=313, Expect=2e-103]} {RNA1310_18147.1} {RNA815_7986} Mlig455_070456 {REF} {Length: 3569} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=176.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.3]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=177, Expect=8e-50]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=175, Expect=3e-49]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=174, Expect=2e-48]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [RH, Score=166, Expect=2e-44]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=215, Expect=4e-64]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=315, Expect=8e-103]} {RNA1310_18147.1} {RNA815_7986} |
51. | MligTC455_39821 | 45 | 0.94 | Mlig455_020248 | Neo: - Age: - |
DRGX | 1.771 | 0.957 | - | 0.814 | - | - | - | Mlig455_020248 {REF} {Length: 1773} {Pfam: Homeodomain [PF00046.31, score=83.1]} {Human: ENSG00000165606, DRGX, dorsal root ganglia homeobox, [RH, Score=132, Expect=4e-35]} {Mouse: ENSMUSG00000041730, Prrxl1, paired related homeobox protein-like 1, [RH, Score=133, Expect=1e-35]} {Dmel: FBgn0085369, Drgx, Dorsal root ganglia homeobox, [RH, Score=152, Expect=3e-40]} {Celegans: WBGene00000440, ceh-17, C. Elegans Homeobox; CEH-17, [Score=112, Expect=3e-28]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [RH, Score=159, Expect=2e-47]} {RNA1310_82891} |
52. | MligTC455_48309 | 2705 | 56.35 | Mlig455_043570 | Neo: - Age: logFC(26M/2M)=0.691 Region-enriched R2: 2.657/0.00096 |
1.769 | - | - | 0.810 | - | 0.959 | - | Mlig455_043570 {REF} {Length: 1257} {TRANSSPLICED} {Pfam: Sep15/SelM redox domain [PF08806.13, score=20.1]} {RNA1509_18693, RNA1509_28224, RNA1509_28351} {RNA1310_24649.1, RNA1509_18693, RNA1509_28351} {RNA1509_18693, RNA1509_28351, RNA815_12206} | |
53. | MligTC455_37838 | 40 | 0.83 | Mlig455_012885 | Neo: - Age: Up-Down-Down |
PKDREJ | 1.768 | 0.952 | - | - | - | 0.816 | - | Mlig455_012885 {REF} {Length: 13341} {Pfam: Polycystin cation channel [PF08016.14, score=221.2]; REJ domain [PF02010.17, score=52.8]; PLAT/LH2 domain [PF01477.25, score=27.5]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=184, Expect=7e-46]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [Score=186, Expect=7e-47]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=178, Expect=3e-44]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=110, Expect=6e-24]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=121, Expect=3e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=260, Expect=1e-69]} {RNA1509_38015} {RNA1310_23208, RNA1509_38015} {RNA1509_38015, RNA815_31966} |
54. | MligTC455_39222 | 213 | 4.44 | Mlig455_064653, Mlig455_064686 | Neo: - Age: - Region-enriched R2: 4.317/0.00597 |
1.767 | 0.976 | - | - | - | 0.791 | - | Mlig455_064653 {REF} {Length: 2836} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.9, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=7e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_56255} {RNA1310_13407} {RNA815_38407} Mlig455_064686 {REF} {Length: 3820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.5, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=8e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_50956} {RNA1310_13407} {RNA815_38407} |
|
55. | MligTC455_23808 | 31 | 0.65 | Mlig455_059306 | Neo: - Age: Down-Down-Up |
1.765 | - | - | 1.000 | - | 0.765 | - | Mlig455_059306 {REF} {Length: 1845} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=30.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042} | |
56. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.761 | 0.966 | - | - | - | 0.795 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
57. | MligTC455_25412 | 199 | 4.15 | Mlig455_008720, Mlig455_063581 | Neo: - Age: - Region-enriched R2: 7.484/0.00035 |
CNBD2 | 1.761 | - | - | 0.991 | - | 0.770 | - | Mlig455_008720 {REF} {Length: 2602} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.1]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=1e-69]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} Mlig455_063581 {REF} {Length: 2668} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=7e-70]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} |
58. | MligTC455_48307 | 5053 | 105.27 | Mlig455_043403, Mlig455_043421 | Neo: - Age: - Region-enriched R2: 2.785/0.00083 |
1.76 | - | - | 0.806 | - | 0.954 | - | Mlig455_043403 {REF} {Length: 1287} {Pfam: Sep15/SelM redox domain [PF08806.13, score=20.1]} {RNA1509_28224} {RNA1310_24649.1} {RNA815_12206} Mlig455_043421 {REF} {Length: 1452} {Pfam: Sep15/SelM redox domain [PF08806.13, score=20.1]} {RNA1509_28224} {RNA1310_24649.1, RNA1509_28224} {RNA1509_28224, RNA815_12206} |
|
59. | MligTC455_19373 | 162 | 3.38 | Mlig455_040143 | Neo: - Age: - |
CFDP1 | 1.755 | - | - | 0.957 | - | 0.798 | - | Mlig455_040143 {REF} {Length: 2641} {TRANSSPLICED} {Pfam: Bucentaur or craniofacial development [PF07572.14, score=96.6]} {Human: ENSG00000153774, CFDP1, craniofacial development protein 1, [RH, Score=123, Expect=5e-32]} {Mouse: ENSMUSG00000031954, Cfdp1, craniofacial development protein 1, [RH, Score=122, Expect=8e-32]} {Dmel: FBgn0267398, Yeti, [RH, Score=89.7, Expect=1e-20]} {Celegans: WBGene00009565, F39H11.1, [RH, Score=75.1, Expect=1e-15]} {Smed: dd_Smed_v6_2321_0_1, dd_Smed_v6_2321_0_1, [RH, Score=87.8, Expect=2e-20]} {RNA1509_18690, RNA1509_30032, RNA1509_31216} {RNA1310_29020, RNA1509_18690, RNA1509_31216} {RNA1509_18690, RNA1509_31216, RNA815_14432.1} |
60. | MligTC455_48127 | 47 | 0.97 | Mlig455_037173 | Neo: - Age: - |
1.754 | - | - | 0.995 | - | 0.759 | - | Mlig455_037173 {REF} {Length: 1938} {RNA1310_42908} {RNA815_22744} | |
61. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 1.753 | 0.966 | - | - | - | 0.787 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
62. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
1.752 | - | - | 0.989 | - | 0.763 | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
63. | MligTC455_27548 | 64 | 1.33 | Mlig455_021305 | Neo: - |
GAA | 1.75 | - | 0.790 | 0.960 | - | - | - | Mlig455_021305 {REF} {Length: 3926} {Pfam: Glycosyl hydrolases family 31 [PF01055.28, score=285.6]} {Human: ENSG00000171298, GAA, glucosidase alpha, acid, [Score=268, Expect=4e-80]; ENSG00000257335, MGAM, maltase-glucoamylase, [Score=261, Expect=4e-76]} {Mouse: ENSMUSG00000025579, Gaa, glucosidase, alpha, acid, [Score=283, Expect=1e-85]} {Dmel: FBgn0027588, GCS2alpha, Glucosidase 2 alpha subunit, [Score=157, Expect=5e-41]} {Celegans: WBGene00017071, aagr-1, Acid Alpha Glucosidase Relate, [Score=200, Expect=6e-56]} {Smed: dd_Smed_v6_4668_0_1, dd_Smed_v6_4668_0_1, [Score=264, Expect=3e-79]} {RNA1509_26177, RNA1509_53093} {RNA1310_3380.1, RNA1509_26177} {RNA1509_26177, RNA815_1621.1} |
64. | MligTC455_53980 | 13 | 0.27 | Mlig455_060865 | Neo: - Age: - |
GABBR2 | 1.75 | 0.955 | - | - | - | 0.795 | - | Mlig455_060865 {REF} {Length: 3682} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.2]; Receptor family ligand binding region [PF01094.30, score=132.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=298, Expect=1e-88]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=297, Expect=2e-88]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=280, Expect=7e-81]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=252, Expect=6e-73]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=137, Expect=2e-36]} {RNA1310_54842} {RNA815_42601} |
65. | MligTC455_53633 | 1960 | 40.84 | Mlig455_043831, Mlig455_047417, Mlig455_070992 | Neo: - Age: - Region-specific R2: 8.211 Region-enriched R2: 9.874/0.00000 |
1.746 | - | - | 0.998 | - | 0.748 | - | Mlig455_043831 {REF} {Length: 1456} {RNA1509_16856} {RNA1310_25970.1, RNA1509_16856} {RNA1509_16856, RNA815_11970} Mlig455_047417 {REF} {Length: 1354} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} Mlig455_070992 {REF} {Length: 1455} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} |
|
66. | MligTC455_14752 | 17 | 0.36 | Mlig455_009102 | Neo: - Age: - |
1.745 | - | 0.785 | 0.960 | - | - | - | Mlig455_009102 {REF} {Length: 1690} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=50.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=89.7, Expect=1e-19]} {RNA1509_4484} {RNA1310_25467} {RNA815_39314} | |
67. | MligTC455_01243 | 37 | 0.77 | Mlig455_055650 | Neo: - Age: - |
1.744 | - | - | 0.994 | - | 0.750 | - | Mlig455_055650 {REF} {Length: 625} {Pfam: Universal stress protein family [PF00582.28, score=20.0]} {RNA1310_33871} {RNA815_28361} | |
68. | MligTC455_32171 | 15 | 0.3 | Mlig455_015340 | Neo: - Age: - |
1.744 | - | - | 1.000 | - | 0.744 | - | Mlig455_015340 {REF} {Length: 2137} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.6]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=4e-14]} {RNA1509_41917} {RNA1310_48467} {RNA815_13028} | |
69. | MligTC455_11776 | 33 | 0.68 | Mlig455_048959 | Neo: - Age: - |
GABBR2 | 1.743 | - | - | 1.000 | - | 0.743 | - | Mlig455_048959 {REF} {Length: 2499} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=162.7]; Receptor family ligand binding region [PF01094.30, score=94.2]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=277, Expect=2e-80]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=273, Expect=5e-79]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=252, Expect=4e-72]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=251, Expect=6e-72]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=134, Expect=4e-35]} {RNA1310_72017} {RNA815_50524} |
70. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.742 | 0.973 | - | - | - | 0.769 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
71. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 1.736 | - | - | 1.000 | - | 0.736 | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
72. | MligTC455_11958 | 26 | 0.54 | Mlig455_035540 | Neo: - Age: - |
1.734 | - | - | 1.000 | - | 0.734 | - | Mlig455_035540 {REF} {Length: 976} {RNA1509_48973} {RNA1310_39954.1} {RNA815_19596} | |
73. | MligTC455_15353 | 85 | 1.78 | Mlig455_015663, Mlig455_062473 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.265 Region-enriched R2: 9.386/0.02025 |
ARRB1 | 1.734 | - | - | 0.995 | - | 0.739 | - | Mlig455_015663 {REF} {Length: 1700} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=68.5]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=52.0]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=261, Expect=1e-83]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=260, Expect=5e-83]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=259, Expect=1e-82]; ENSMUSG00000060890, Arr3, arrestin 3, retinal, [Score=253, Expect=9e-81]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=252, Expect=6e-80]} {Dmel: FBgn0040206, krz, kurtz, [Score=256, Expect=3e-81]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=235, Expect=2e-73]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=321, Expect=4e-106]} {RNA1509_59210} {RNA1310_21679, RNA1509_59210} {RNA1509_59210, RNA815_10578.1} Mlig455_062473 {REF} {Length: 1703} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=71.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=57.4]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=268, Expect=5e-86]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=268, Expect=4e-86]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=265, Expect=5e-85]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=260, Expect=5e-83]} {Dmel: FBgn0040206, krz, kurtz, [Score=259, Expect=3e-82]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=239, Expect=8e-75]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=328, Expect=3e-109]} {RNA1509_59210} {RNA1310_21679} {RNA815_10578.1} |
74. | MligTC455_18206 | 16 | 0.34 | Mlig455_035191 | Neo: - Age: - |
KCNA2 | 1.734 | - | - | 1.000 | - | 0.734 | - | Mlig455_035191 {REF} {Length: 2646} {Pfam: Ion transport protein [PF00520.33, score=133.9]; BTB/POZ domain [PF02214.24, score=84.1]; Ion channel [PF07885.18, score=52.6]} {Human: ENSG00000177301, KCNA2, potassium voltage-gated channel subfamily A member 2, [Score=399, Expect=9e-134]; ENSG00000111262, KCNA1, potassium voltage-gated channel subfamily A member 1, [Score=395, Expect=1e-132]; ENSG00000177272, KCNA3, potassium voltage-gated channel subfamily A member 3, [Score=385, Expect=1e-127]; ENSG00000182255, KCNA4, potassium voltage-gated channel subfamily A member 4, [Score=382, Expect=1e-125]} {Mouse: ENSMUSG00000040724, Kcna2, potassium voltage-gated channel, shaker-related subfamily, member 2, [Score=401, Expect=8e-135]; ENSMUSG00000047976, Kcna1, potassium voltage-gated channel, shaker-related subfamily, member 1, [Score=395, Expect=8e-133]; ENSMUSG00000047959, Kcna3, potassium voltage-gated channel, shaker-related subfamily, member 3, [Score=390, Expect=3e-130]; ENSMUSG00000042604, Kcna4, potassium voltage-gated channel, shaker-related subfamily, member 4, [Score=383, Expect=7e-126]} {Dmel: FBgn0003380, Sh, Shaker, [Score=395, Expect=5e-131]} {Celegans: WBGene00014261, shk-1, Potassium voltage-gated channel protein shk-1, [Score=290, Expect=7e-93]} {Smed: dd_Smed_v6_15133_0_1, dd_Smed_v6_15133_0_1, [RH, Score=550, Expect=0.0]} {RNA1509_46497} {RNA1310_11183} {RNA815_28293} |
75. | MligTC455_04170 | 65 | 1.36 | Mlig455_000555, Mlig455_030353 | Neo: - Age: - |
FGG | 1.733 | - | 0.763 | 0.970 | - | - | - | Mlig455_000555 {REF} {Length: 1133} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=125.0]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=103, Expect=3e-24]; ENSG00000120332, TNN, tenascin N, [Score=98.2, Expect=3e-22]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=6e-25]; ENSMUSG00000026938, Fcna, ficolin A, [Score=99.4, Expect=1e-23]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=98.2, Expect=9e-23]; ENSMUSG00000026725, Tnn, tenascin N, [Score=98.2, Expect=2e-22]} {Dmel: FBgn0051832, CG31832, [Score=88.2, Expect=2e-20]} {Celegans: WBGene00020516, T15B7.1, [Score=62.4, Expect=8e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_33683.2} {RNA815_41841} Mlig455_030353 {REF} {Length: 1214} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.3]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=103, Expect=3e-24]; ENSG00000120332, TNN, tenascin N, [Score=99.4, Expect=3e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=6e-23]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=1e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=1e-23]; ENSMUSG00000026725, Tnn, tenascin N, [Score=99.0, Expect=2e-22]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=99.0, Expect=9e-23]} {Dmel: FBgn0051832, CG31832, [Score=92.0, Expect=9e-22]} {Celegans: WBGene00020516, T15B7.1, [Score=63.2, Expect=4e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=75.9, Expect=4e-15]} {RNA1310_33683.2} {RNA815_41841} |
76. | MligTC455_14400 | 10 | 0.21 | Mlig455_016543 | Neo: - Age: - |
SULT1A1 | 1.732 | - | - | 1.000 | - | 0.732 | - | Mlig455_016543 {REF} {Length: 1270} {Pfam: Sulfotransferase domain [PF00685.29, score=203.8]; Sulfotransferase family [PF13469.8, score=34.0]} {Human: ENSG00000196502, SULT1A1, sulfotransferase family 1A member 1, [Score=167, Expect=1e-48]; ENSG00000198075, SULT1C4, sulfotransferase family 1C member 4, [Score=167, Expect=8e-49]; ENSG00000261052, SULT1A3, sulfotransferase family 1A member 3, [Score=163, Expect=2e-47]; ENSG00000213648, SULT1A4, sulfotransferase family 1A member 4, [Score=163, Expect=2e-47]; ENSG00000197165, SULT1A2, sulfotransferase family 1A member 2, [Score=161, Expect=2e-46]; ENSG00000198203, SULT1C2, sulfotransferase family 1C member 2, [Score=160, Expect=5e-46]} {Mouse: ENSMUSG00000023122, Sult1c2, sulfotransferase family, cytosolic, 1C, member 2, [Score=169, Expect=1e-49]; ENSMUSG00000029269, Sult1b1, sulfotransferase family 1B, member 1, [Score=166, Expect=2e-48]} {Dmel: FBgn0037665, St2, Sulfotransferase 2, [Score=130, Expect=6e-35]} {Celegans: WBGene00013748, ssu-1, Suppressor of Stomatin mutant Uncoordination, [Score=110, Expect=5e-27]} {Smed: dd_Smed_v6_34919_0_1, dd_Smed_v6_34919_0_1, [RH, Score=275, Expect=3e-91]} {RNA1310_95833} |
77. | MligTC455_22212 | 1732 | 36.09 | Mlig455_009239, Mlig455_009645, Mlig455_037058 | Neo: - Age: logFC(26M/2M)=-0.722 Region-specific R2: 6.329 Region-enriched R2: 6.728/0.00000 |
LMNA | 1.732 | - | - | 0.991 | - | 0.741 | - | Mlig455_009239 {REF} {Length: 2842} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_009645 {REF} {Length: 2337} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_037058 {REF} {Length: 4944} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1310_9741.1, RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1509_18286, RNA1509_31019, RNA1509_37437, RNA815_3167} |
78. | MligTC455_54721 | 10 | 0.21 | Mlig455_008906 | Neo: - Age: - |
SULT1A1 | 1.732 | - | - | 1.000 | - | 0.732 | - | Mlig455_008906 {REF} {Length: 1120} {Pfam: Sulfotransferase domain [PF00685.29, score=204.5]; Sulfotransferase family [PF13469.8, score=34.6]} {Human: ENSG00000196502, SULT1A1, sulfotransferase family 1A member 1, [RH, Score=162, Expect=2e-47]} {Mouse: ENSMUSG00000023122, Sult1c2, sulfotransferase family, cytosolic, 1C, member 2, [Score=168, Expect=5e-50]; ENSMUSG00000029269, Sult1b1, sulfotransferase family 1B, member 1, [Score=166, Expect=3e-49]} {Dmel: FBgn0037665, St2, Sulfotransferase 2, [Score=129, Expect=8e-35]} {Celegans: WBGene00013748, ssu-1, Suppressor of Stomatin mutant Uncoordination, [Score=110, Expect=2e-27]} {Smed: dd_Smed_v6_34919_0_1, dd_Smed_v6_34919_0_1, [RH, Score=274, Expect=2e-91]} {RNA1310_95833} |
79. | MligTC455_14983 | 22 | 0.46 | Mlig455_057872 | Neo: - Age: - |
1.731 | - | - | 1.000 | - | 0.731 | - | Mlig455_057872 {REF} {Length: 2237} {Pfam: Universal stress protein family [PF00582.28, score=43.9]} {Smed: dd_Smed_v6_1092_0_1, dd_Smed_v6_1092_0_1, [Score=58.9, Expect=8e-12]} {RNA1509_41553} {RNA1310_86520} {RNA815_43126} | |
80. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 1.73 | 0.736 | - | 0.994 | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
81. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
1.73 | - | - | 0.997 | - | 0.733 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
82. | MligTC455_27332 | 6690 | 139.38 | Mlig455_034839, Mlig455_034841, Mlig455_034842 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.609 Region-specific R2: 8.988 Region-enriched R2: 9.169/0.00000 Regeneration-depleted R2: -8.701 |
1.729 | - | - | 0.991 | - | 0.738 | - | Mlig455_034839 {REF} {Length: 551} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} Mlig455_034841 {REF} {Length: 529} {RNA1509_2874} {RNA1310_102625.1, RNA1509_2874} {RNA1509_2874, RNA815_20834} Mlig455_034842 {REF} {Length: 557} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} |
|
83. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
1.726 | - | - | 0.988 | - | 0.738 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
84. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 1.724 | - | - | 0.970 | - | 0.754 | - | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
85. | MligTC455_27786 | 197 | 4.11 | Mlig455_001303 | Neo: - Age: Up-Down-Down Region-specific R2: 6.990 Region-enriched R2: 6.421/0.02381 |
HMCN2 | 1.722 | - | - | 0.997 | - | 0.725 | - | Mlig455_001303 {REF} {Length: 2154} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.5]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=5e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_4579} {RNA1310_19586} {RNA815_17693} |
86. | MligTC455_32172 | 14 | 0.29 | Mlig455_015389 | Neo: Irradiation Age: - |
1.722 | - | - | 1.000 | - | 0.722 | - | Mlig455_015389 {REF} {Length: 1732} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=39.2]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.0, Expect=7e-14]} {RNA1509_23615} {RNA1310_5589.2} {RNA815_10426} | |
87. | MligTC455_14500 | 10 | 0.21 | Mlig455_017108 | Neo: - Age: Down-Up-Up |
SSTR1 | 1.721 | - | - | 1.000 | - | 0.721 | - | Mlig455_017108 {REF} {Length: 2868} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=119.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=115, Expect=8e-28]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=116, Expect=4e-28]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [Score=121, Expect=2e-29]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [RH, Score=112, Expect=2e-26]} {Smed: dd_Smed_v6_14519_0_1, dd_Smed_v6_14519_0_1, [Score=122, Expect=1e-30]} {RNA1310_55087} {RNA815_31043} |
88. | MligTC455_32575 | 62 | 1.29 | Mlig455_024198 | Neo: - Age: logFC(26M/2M)=-0.353 |
FAT4 | 1.72 | - | - | 0.979 | - | 0.741 | - | Mlig455_024198 {REF} {Length: 7971} {Pfam: Cadherin domain [PF00028.19, score=704.5]; Cadherin-like [PF16184.7, score=77.6]; Cadherin-like [PF08266.14, score=39.5]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=501, Expect=3e-142]; ENSG00000107736, CDH23, cadherin related 23, [Score=498, Expect=1e-141]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=514, Expect=1e-146]; ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=504, Expect=1e-143]} {Dmel: FBgn0284247, ds, dachsous, [Score=457, Expect=3e-129]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=277, Expect=2e-74]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=276, Expect=8e-74]} {RNA1509_24504} {RNA1310_3168, RNA1509_24504} {RNA1509_24504, RNA815_13217} |
89. | MligTC455_27330 | 2939 | 61.23 | Mlig455_029694 | Neo: - Age: - Region-specific R2: 5.698 Region-enriched R2: 5.201/0.00000 Regeneration-downregulated R2: -3.996 Regeneration-depleted R2: -3.996 |
1.719 | - | - | 0.988 | - | 0.731 | - | Mlig455_029694 {REF} {Length: 2374} {TRANSSPLICED} {RNA1509_22512} {RNA1310_16498, RNA1509_22512} {RNA1509_22512, RNA815_17345} | |
90. | MligTC455_54106 | 87 | 1.81 | Mlig455_046338, Mlig455_068234 | Neo: Int S/G2/M Age: Up-Down-Down |
PLCB1, PLCB3 | 1.719 | - | - | 0.957 | - | 0.762 | - | Mlig455_046338 {REF} {Length: 4577} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.8]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=69.3]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.5]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [Score=797, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [Score=796, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [Score=801, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [Score=784, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=418, Expect=4e-125]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=671, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=702, Expect=0.0]} {RNA1509_50989} {RNA1310_17477} {RNA815_25811} Mlig455_068234 {REF} {Length: 4646} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=123.2]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.4]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=837, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=831, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=830, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=827, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=444, Expect=7e-134]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=684, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=716, Expect=0.0]} {RNA1509_50989} {RNA1310_17477, RNA1509_50989} {RNA1509_50989, RNA815_25811} |
91. | MligTC455_13094 | 121 | 2.52 | Mlig455_005442, Mlig455_005513 | Neo: - Age: Up-Up-Down |
1.718 | 0.959 | - | - | - | 0.759 | - | Mlig455_005442 {REF} {Length: 3816} {Smed: dd_Smed_v6_15433_0_1, dd_Smed_v6_15433_0_1, [Score=141, Expect=1e-34]} {RNA1509_41201} {RNA1310_51044} {RNA815_32534} Mlig455_005513 {REF} {Length: 685} {NoTransDecoderORF} {RNA1310_56412} {RNA815_32534} |
|
92. | MligTC455_11395 | 28 | 0.59 | Mlig455_048035 | Neo: - Age: - |
RASL10B | 1.715 | 0.960 | - | - | - | 0.755 | - | Mlig455_048035 {REF} {Length: 2464} {Pfam: Ras family [PF00071.24, score=93.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=38.8]; ADP-ribosylation factor family [PF00025.23, score=23.1]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=148, Expect=5e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=149, Expect=3e-44]} {Dmel: FBgn0037326, CG14669, [Score=115, Expect=2e-30]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=81.3, Expect=9e-19]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=164, Expect=2e-49]} |
93. | MligTC455_37047 | 45 | 0.94 | Mlig455_046180 | Neo: - Age: - |
1.715 | 0.989 | - | - | - | 0.726 | - | Mlig455_046180 {REF} {Length: 1686} {RNA1310_140241} {RNA815_12716} | |
94. | MligTC455_13421 | 86 | 1.79 | Mlig455_036504, Mlig455_069144 | Neo: - Age: - |
SYT17 | 1.714 | 0.959 | - | - | - | 0.755 | - | Mlig455_036504 {REF} {Length: 2390} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} Mlig455_069144 {REF} {Length: 1355} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} |
95. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 1.712 | - | - | 0.982 | - | 0.730 | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
96. | MligTC455_43875 | 9 | 0.19 | Mlig455_069048 | Neo: - Age: - |
1.712 | - | - | 1.000 | - | 0.712 | - | Mlig455_069048 {REF} {Length: 575} {NoTransDecoderORF} {RNA1310_139137} | |
97. | MligTC455_16471 | 45 | 0.94 | Mlig455_042944 | Neo: - Age: - |
NKX2-3 | 1.711 | 0.711 | - | 1.000 | - | - | - | Mlig455_042944 {REF} {Length: 1426} {Pfam: Homeodomain [PF00046.31, score=67.5]} {Human: ENSG00000119919, NKX2-3, NK2 homeobox 3, [RH, Score=122, Expect=1e-31]} {Mouse: ENSMUSG00000044220, Nkx2-3, NK2 homeobox 3, [RH, Score=122, Expect=2e-31]} {Dmel: FBgn0028993, scro, scarecrow, [Score=106, Expect=3e-26]} {Celegans: WBGene00000450, ceh-28, C. Elegans Homeobox; NK-2 family homeodomain protein CEH-28, [RH, Score=97.8, Expect=4e-24]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [Score=109, Expect=3e-27]} {RNA1310_91075} |
98. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 1.71 | 0.966 | - | - | - | 0.744 | - | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
99. | MligTC455_46554 | 47 | 0.97 | Mlig455_038253 | Neo: - Age: logFC(26M/2M)=-0.562 |
1.71 | 0.710 | - | 1.000 | - | - | - | Mlig455_038253 {REF} {Length: 1890} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=60.6]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=94.4, Expect=7e-24]} {RNA1310_40614} {RNA815_32173} | |
100. | MligTC455_40707 | 15 | 0.31 | Mlig455_033559, Mlig455_067009 | Neo: - Age: - |
GRIK2 | 1.707 | 0.959 | - | - | - | 0.748 | - | Mlig455_033559 {REF} {Length: 3723} {tRNA: Val(CAC),pseudo, score=30.0} {Pfam: Ligand-gated ion channel [PF00060.28, score=144.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=101.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=66.3]; Receptor family ligand binding region [PF01094.30, score=22.9]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=325, Expect=4e-97]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=318, Expect=2e-94]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=309, Expect=8e-91]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=323, Expect=2e-96]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=316, Expect=2e-93]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=310, Expect=3e-92]} {Dmel: FBgn0038837, CG3822, [Score=292, Expect=2e-85]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=252, Expect=8e-71]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=357, Expect=2e-108]} {RNA1310_11982.1} {RNA815_20096} Mlig455_067009 {REF} {Length: 2583} {Pfam: Ligand-gated ion channel [PF00060.28, score=121.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=101.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=46.3]; Receptor family ligand binding region [PF01094.30, score=22.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=267, Expect=1e-76]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=265, Expect=2e-75]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=260, Expect=7e-74]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=267, Expect=1e-76]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=262, Expect=1e-74]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=259, Expect=2e-74]} {Dmel: FBgn0038837, CG3822, [Score=234, Expect=2e-65]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=208, Expect=2e-56]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=281, Expect=2e-81]} {RNA1310_11982.1} {RNA815_20096} |